[20 November 2024] JNET Vol.18 Iss.11 now available.
[1 January 2024] JNET has updated the Instructions to Authors with the following changes:
- Structural changes to Technical Notes
- Declaration of ORCID IDs (optional)
Instructions to Authors
https://www.jnet-ejournal.org/en/authors/
[29 July 2023] We are excited to announce that our journal JNET has been accepted for inclusion in the PMC (PubMed Central) database.
PMC：https://www.ncbi.nlm.nih.gov/pmc/journals/4438/
JNET Journal of Neuroendovascular Therapy is a peer reviewed, open access journal that publishes significant and novel contributions in neuroendovascular therapy. The journal, which is supported by The Japanese Society for Neuroendovascular Therapy (JSNET), aims to facilitate communication and progress in the field of neurointervention worldwide. Article types include Original Articles, Case Reports, Technical Notes, Anatomical Imaging Articles, Review Articles and Letters to the Editor.
The journal publishes articles related to neuroendovascular therapy in the fields of general medicine, social medicine, clinical medicine, and related subjects. Articles can take basic, experimental, applied, or clinical approaches, and the journal welcomes articles that present work at the interface of these areas.
The journal provides its authors with rapid but rigorous peer review. Articles are available freely online as soon as they are published and are collated into issues 12 times a year. They are a vital resource for the journal’s broad global audience of researchers and clinicians.
JNET Journal of Neuroendovascular Therapy is the official journal of the Japanese Society for Neuroendovascular Therapy. The Editorial Board has complete and sole responsibility for all editorial decisions; full details on editorial policy are available in the Instructions to Authors. The Editorial Board can be found here. The Editorial Office is managed by International Academic Publishing Co., Ltd. on behalf of the Society and the Editors.
Journal Title: JNET Journal of Neuroendovascular Therapy
Published by:
The Japanese Society for Neuroendovascular Therapy
http://jsnet.website/documents.php?id=646
Online ISSN : 2186-2494
Print ISSN : 1882-4072
ISSN-L : 1882-4072
Frequency of Publication: Twelve issues per year
Inaugural issue: October, 2007
Electronic Links: J-STAGE https://www.jstage.jst.go.jp/browse/jnet/-char/en
JNET is fully Open Access and uses a Creative Commons license that allows users to conditionally use and reuse the material published in the journal without charge or the need to ask prior permission from the publisher or author.
Authors are required to assign all copyrights in the work to JSNET.
Articles are published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This license allows users to share unmodified articles non-commercially, as long as appropriate credit is given. Any commercial use requires permission from JSNET.
The journal uses double-blind peer review. When a manuscript is submitted to the journal, it is assigned to the Editor-in-Chief, who performs initial screening. Manuscripts that do not fit the journal’s scope or are not deemed suitable for publication are rejected without review. The remaining manuscripts are assigned to an Associate Editor who finds two external reviewers to assess each manuscript. Reviewers are selected based on their expertise, reputation, and previous experience as peer reviewers.
Upon receipt of the two reviewers’ reports, the Associate Editor makes the first decision on the manuscript. If authors are invited to revise their manuscript, they should respond to each review comment in turn, and indicate the modifications with page and line numbers. The modified parts of the text should be highlighted by underlining or coloring.
Authors who are invited to revise their manuscript must do so by the deadline set out in the decision letter; resubmissions after this deadline may be treated as new submissions. The Associate Editor may send revised manuscripts to peer reviewers for their feedback or may use his or her own judgement to assess how closely the authors have followed the Associate Editor’s and the reviewers’ comments on the original manuscript.
The Associate Editor then makes a recommendation to the Editor-in-Chief on the manuscript’s suitability for publication. The Editor-in-Chief is responsible for making the final decision on each manuscript.
Special issues undergo the same review process as regular articles and Associate Editors for special issues are appointed from the members of the Editorial Committee.
The members of the Editorial Committee act in advisory roles, providing feedback as reviewers and making suggestions to improve the journal. The external board members consist of experts in fields outside of medicine relevant to the journal's scope, selected by the Editorial Committee. The external board members do not directly participate in the review process but provide advice to the editorial committee on matters related to "statistics," "medical ethics," and "radiation protection and exposure." In cases where the Editor-in-Chief is an author on a manuscript submitted to the journal, a member of the Editorial Committee is responsible for making the final decision on the manuscript's suitability for publication in the journal.